Vanguard Rapid Resp 3 Canine Intranasal Vaccine

فانغارد رابيد ريسب 3 لقاح الأنف للكلاب

Compare
Biological

Vanguard Rapid Resp 3 is a modified-live viral and bacterial vaccine containing attenuated Bordetella bronchiseptica, Canine Parainfluenza virus, and Canine Adenovirus Type 2 for intranasal administration to dogs. Indicated for the active vaccination of healthy dogs and puppies 3 weeks of age or older to aid in the prevention of canine infectious respiratory disease complex (kennel cough).

Dosage Form

N/A

Product Type

Biological

Manufacturer

Zoetis

Package

Packs of 25 x 1 dose vials with sterile diluent and nasal applicator tips

Dosages

No dosage information available.

Withdrawal Periods

Species Meat (days) Milk (days) Eggs (days)

Indications

  • Vaccination of healthy dogs 3 weeks of age or older to aid in the prevention of canine infectious respiratory disease complex (kennel cough) caused by Bordetella bronchiseptica, Canine Parainfluenza virus, and Canine Adenovirus Type 2.

    تحصين الكلاب والجراء من عمر 3 أسابيع عبر الأنف للوقاية السريعة من متلازمة سعال الفقمة (سعال الكلاب) الناتجة عن البورديتيلا وفيروس نظير الإنفلونزا والفيروس الغدي النمط 2.

Contraindications

No contraindications information available.

Precautions

  • For intranasal use only. If accidentally injected subcutaneously, transient hepatic abscessation or anaphylaxis may occur.

    للاستخدام الأنفي فقط؛ الحقن العرضي بالخطأ قد يؤدي لتكون خراجات أو ردود فعل موضعية شديدة.

Side Effects

  • Transient sneezing, coughing, or clear ocular/nasal discharge for 2 to 4 days post-vaccination.

    عطاس خفيف، سعال عابر، أو إفرازات أنفية دمعية بسيطة خلال 2-4 أيام بعد التطعيم تزول تلقائياً.

Images

Documents

  • Vanguard Rapid Resp 3 Prescribing Information

    Leaflet
    Download

Diseases

No diseases linked.

Related Products

No data available

Information has not been added yet.

Related Products By Active Ingredient

Companies

Alternatives

No alternatives available.

This website uses cookies to ensure you get the best experience.